Verve Therapeutics, Inc.

NASDAQ:VERV

6.24 (USD) • At close January 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 158.709141.49144.2206.1878.3770.042508.687115.412550.7172.88991.4264.33148.134387.44699.3978.993-18.782
Short Term Investments 381.211434.458462.167417.77406.856392.434424.941439.396273.691220.672231.879296.112241.07630.17850.12663.11937.564
Cash and Short Term Investments 539.92575.948606.367623.95485.226462.476508.687554.808550.71293.561323.299360.442389.21417.624149.52372.11218.782
Net Receivables 2.6283.045.7675.8973.1452.0931.4041.0120.92900000000
Inventory 000000-9.10000000000
Other Current Assets 13.91111.8998.1928.1029.898.4977.6967.3399.99110.16611.06213.37210.4543.882.3181.8540
Total Current Assets 556.459590.887620.326637.949498.261473.066508.687563.159561.63298.644328.83367.128394.437419.564151.84173.96618.782
Non-Current Assets:
Property, Plant & Equipment, Net 99.546101.931104.551107.8107.844110.018111.056110.655106.49113.19312.4729.0638.9096.4175.2023.9840
Goodwill 00000000000000000
Intangible Assets 00000000000000000
Goodwill and Intangible Assets 00000000000000000
Long Term Investments 04.7744.7744.7744.7744.8244.8244.8244.8245.2375.2375.2375.2370.4630.46300
Tax Assets 00000000000000000
Other Non-Current Assets 7.9013.3182.7062.1651.5281.2239.8090.5850.417.1932.7022.6962.2940.0740.6630.463-18.782
Total Non-Current Assets 107.447110.023112.031114.739114.146116.065125.689116.064111.72525.62320.41116.99616.446.9546.3284.447-18.782
Total Assets 663.906700.91732.357752.688612.407589.131634.376679.223673.355324.267349.241384.124410.877426.518158.16978.4130
Liabilities & Equity:
Current Liabilities:
Account Payables 4.6376.8333.0496.6361.0543.1463.3722.4240.4656.322.4387.0773.5791.532.4870.0360
Short Term Debt 20.73620.58610.2220.38420.23620.09222.36823.80817.8081.8142.8641.9554.590000
Tax Payables 00000000000000000
Deferred Revenue 5.7193.4791.47348.55648.55420.01420.01420.01420.01400-12.9928.1270.1520.13600
Other Current Liabilities 11.559.46916.5529.98613.2859.7937.8128.86310.74517.7139.50112.99212.0827.1194.0617.2790
Total Current Liabilities 42.64240.36731.29437.00634.57533.03133.55235.09529.01825.84714.80322.02420.2518.6496.6847.3150
Non-Current Liabilities:
Long Term Debt 60.88762.18363.45464.71566.68967.81968.92770.01471.0110000.1810218.91900
Deferred Revenue Non-Current 50.73151.15351.73348.55648.55420.01420.01420.01420.01400000.0130.05300
Deferred Tax Liabilities Non-Current 00000000000000-218.97200
Other Non-Current Liabilities 1.0951.1132.8072.9092.223.0452.4073.1685.3692.0873.0484.7485.5112.4738.944135.0070
Total Non-Current Liabilities 112.713114.449117.994116.18117.46390.87891.34893.19696.3942.0873.0484.7485.69112.473227.916135.0070
Total Liabilities 155.355154.816149.288153.186152.038123.909124.9128.291125.41227.93417.85126.77225.94221.122234.6142.3220
Equity:
Preferred Stock 000000000000410.877426.518218.919125.1625.48
Common Stock 0.0850.0850.0840.0820.0640.0620.0620.0620.0610.0490.0490.0490.0480.0480.0030.0030
Retained Earnings -692.979-642.846-593.041-544.305-495.953-450.195-396.212-344.237-303.152-257.962-217.016-186.85-155.513-132.764-79.799-66.5360
Accumulated Other Comprehensive Income/Loss 1.143-0.615-0.50.272-0.597-0.754-0.237-0.694-0.92-0.938-0.732-0.228-0.0020.0030.0070.008-19.553
Other Total Stockholders Equity 1,200.3021,189.471,176.5261,143.453956.855916.109905.863895.801851.954555.184549.089544.381540.402538.1093.3582.6160
Total Shareholders Equity 508.551546.094583.069599.502460.369465.222509.476550.932547.943296.333331.39357.352384.935405.396-76.431-63.9095.927
Total Equity 508.551546.094583.069599.502460.369465.222509.476550.932547.943296.333331.39357.352384.935405.396-76.431-63.9095.927
Total Liabilities & Shareholders Equity 663.906700.91732.357752.688612.407589.131634.376679.223673.355324.267349.241384.124410.877426.518158.16978.4135.927